NCT04700865View on ClinicalTrials.gov

The South-Norway Atrial Fibrillation Screening Study

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

AF screening

Continous ECG monitoring for minimum 3 days

Trial Locations (1)

4809

Sorlandet Hospital, Arendal

All Listed Sponsors
lead

Sorlandet Hospital HF

OTHER_GOV

NCT04700865 - The South-Norway Atrial Fibrillation Screening Study | Biotech Hunter | Biotech Hunter